Background Transcatheter aortic valve replacement (TAVR) has increasingly emerged as one of the primary treatments for ...

Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat ...

CorWave, a company pioneering innovative cardiac assist devices and currently conducting a clinical investigation following the first implantations of its undulating membrane heart pump, announces the ...

After nearly seven years, Chevon Byfield finally found his perfect match: a large, and strong, beating heart. “I feel like, ...

The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.

Solo Pace Incorporated, an emerging medical technology company, today announced the commercial release of the SoloPace FUSION(TM) Temporary Pacing System. The launch follows US Food and Drug ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally ...

The first randomized trial to compare standard percutaneous coronary intervention (PCI), also known as coronary angioplasty, with PCI accompanied by the use of a temporary, miniaturized pump to ...

Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two randomized ...

The results challenge the rapid growth of Impella support during high-risk PCI. Investigators say a reckoning is needed.

The first randomized trial to compare standard percutaneous coronary intervention (PCI), also known as coronary angioplasty, with PCI accompanied by the use of a temporary, miniaturized pump to ...

A combination of left ventricular support plus delayed percutaneous coronary intervention did not reduce infarct size compared with immediate PCI in patients with anterior STEMI without shock, ...